Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADC Agree

Trading 08-26 11:46:13 EDT

74.15

-0.17

-0.23%

High74.65	Low73.93	Vol284.45K
Open74.24	D1 Closing74.32	Amplitude0.96%
Mkt Cap9.22B	Tradable Cap9.06B	Total Shares124.38M
T/O21.11M	T/O Rate0.23%	Tradable Shares122.18M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"Agree","latestPrice":74.15,"timestamp":1787759170978,"preClose":74.32,"halted":0,"volume":284451,"delay":0,"changeRate":-0.0022874058127016618,"floatShares":122178283,"shares":124379300,"eps":1.85165,"marketStatus":"Trading","change":-0.17,"latestTime":"08-26 11:46:13 EDT","open":74.235,"high":74.645,"low":73.93,"amount":21112150.913445003,"amplitude":0.009621,"askPrice":74.15,"askSize":200,"bidPrice":74.12,"bidSize":4,"shortable":3,"etf":0,"ttmEps":1.85165,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787774400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":74.32,"dividendRate":0.04236,"preHourTrading":{"tag":"盘前","latestPrice":74.32,"preClose":74.32,"latestTime":"08:53 EDT","volume":283,"amount":21151.459619999998,"timestamp":1787748794159,"change":0,"changeRate":0,"amplitude":0.013303},"postHourTrading":{"tag":"盘后","latestPrice":74.32,"preClose":74.32,"latestTime":"19:30 EDT","volume":111184,"amount":8263199.28,"timestamp":1787700601457,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.327893,"impliedVol":0.2073,"impliedVolPercentile":0.2311},"requestUrl":"/m/hq/s/ADC/","defaultTab":"news","newsList":[{"id":"2662160207","title":"CanSino Biologics, deepGeneAI Agree to Develop Personalized mRNA Cancer Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=2662160207","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662160207?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:08","pubTimestamp":1787746092,"startTime":"0","endTime":"0","summary":"CanSino Biologics'  subsidiary CanSino  Biological Research entered into a strategic cooperation framework agreement with deepGeneAI to jointly develop personalized mRNA therapeutic cancer vaccines.The companies will explore combining CanSino's mRNA vaccine technology with deepGeneAI's tumor neoantigen discovery and design capabilities, according to a Wednesday Hong Kong bourse filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4231","BK4080","BK1191","NETL","ADC","BK1515","BK1574","BK1161","06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662974537","title":"CSPC’s EGFR-Targeting ADC Hits Phase III Milestone in Resistant Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662974537","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662974537?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:07","pubTimestamp":1787738864,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group ( ($HK:1093) ) has issued an announcement. CSPC Pharmaceutical Group reported that its investigational drug SYS6010, an E...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cspcs-egfr-targeting-adc-hits-phase-iii-milestone-in-resistant-lung-cancer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cspcs-egfr-targeting-adc-hits-phase-iii-milestone-in-resistant-lung-cancer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4134","ADC","BK4080","BK4231","III","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662783122","title":"Market Chatter: Hyundai Motor, Labor Union Agree on Tentative Wage Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2662783122","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662783122?lang=en_us&edition=fundamental","pubTime":"2026-08-25 12:02","pubTimestamp":1787630574,"startTime":"0","endTime":"0","summary":"The management and 400,000-member labor union of Hyundai Motor  reached a possible wage agreement early on Tuesday after the union staged 60 hours of strikes this year that led to production disruptions and significant sales losses, Yonhap News reported the same day.The strikes caused about 120 hours of production disruptions and are estimated to have lowered output by 55,200 vehicles, with lost sales surpassing 2.3 trillion won, the report said.Under the deal, monthly base pay will increase by 100,000 won, while workers will receive a performance bonus of over 400% of monthly salary and an additional 12.5 million won payment. The parties also agreed to extend the retirement age from 60 to 65 if relevant laws are revised, it said.The agreement will be subject to a union vote on Aug. 31, the report said.Hyundai Motor did not immediately respond to MT Newswires' request for comment.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4231","ADC","EEMO","NETL","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661244061","title":"Greenvale, Patronus Agree to Amend Timetable for Northern Territory Project Uranium Rights Acquisition; Greenvale Shares Jump 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661244061","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661244061?lang=en_us&edition=fundamental","pubTime":"2026-08-24 09:45","pubTimestamp":1787535931,"startTime":"0","endTime":"0","summary":"Greenvale Energy  mutually agreed with Patronus Resources  to amend the timetable for completion of the remaining conditions to complete the proposed acquisition of the uranium rights over the Pine Creek project in the Northern Territory, according to a Monday Australian bourse filing.Greenvale's legal due diligence for the deal has been completed, and its only remaining individual condition is shareholder approval for the issue of consideration shares to Patronus at a meeting on Monday.Greenvale began discussions with Patronus regarding the potential for it to begin initial fieldwork programs at Pine Creek during the current field season.Patronus' shares rose 2% in recent trading, while those of Greenvale jumped 8%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NLR","BK7142","PTN.AU","BK4231","BK7095","URNJ","BK4080","SETM","GRV.AU","NETL","BK4606","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661821759","title":"Agree Realty (ADC) Could Be 13% Undervalued On Its Monthly Dividend Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2661821759","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661821759?lang=en_us&edition=fundamental","pubTime":"2026-08-23 09:21","pubTimestamp":1787448112,"startTime":"0","endTime":"0","summary":"Agree Realty (ADC) has declared a monthly dividend of US$0.2670 per share, payable on September 15, 2026. The ex-dividend and record dates are both set for August 31, 2026.\nSee our latest analysis for Agree Realty.\nAgree Realty's share price has eased in recent weeks, with a 1-month share price return of down 7.9% and a year to date share price return of 2.44%. The 1-year total shareholder return of 5.39% and 3-year total shareholder return of 35.94% point to a stronger longer term record.\nIf...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-adc/agree-realty/news/agree-realty-adc-could-be-13-undervalued-on-its-monthly-divi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-adc/agree-realty/news/agree-realty-adc-could-be-13-undervalued-on-its-monthly-divi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4080","ADC","NETL","ADC.AU","BK7095","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661919862","title":"Hidropar Shareholders Agree $6.5 Million Control-Change Deal With New Investor","url":"https://stock-news.laohu8.com/highlight/detail?id=2661919862","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661919862?lang=en_us&edition=fundamental","pubTime":"2026-08-21 23:46","pubTimestamp":1787327197,"startTime":"0","endTime":"0","summary":"An announcement from HIDROPAR HAREKET KONTROL TEKNOLOJILERI MERKEZI SANAYI VE TICARET ANONIM SIRKETI ( ($TR:HKTM) ) is now available. Hidropar disc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hidropar-shareholders-agree-6-5-million-control-change-deal-with-new-investor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hidropar-shareholders-agree-6-5-million-control-change-deal-with-new-investor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","NETL","BK4080","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661525835","title":"China, Switzerland Agree On Trade Deal Scrapping Most Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2661525835","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661525835?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:58","pubTimestamp":1787266730,"startTime":"0","endTime":"0","summary":"China and Switzerland have agreed on a new trade accord granting 99.8% of Switzerland's current exports to China tariff-free treatment, Bloomberg reported Thursday.The deal also gives Swiss investors improved access to the Chinese market, while watches, pharmaceuticals and precision instruments will be able to enter China duty-free, Bloomberg said.The accord could provide some relief to Switzerland's export-oriented economy amid uncertainty over US trade policy, the report said.China is Switzerland's third-largest trading partner after the European Union and the US, with bilateral shipments totaling about 34 billion francs last year, Bloomberg said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4231","BK4080","ADC","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163462206","title":"CSTONE PHARMA-B Gets NMPA Green Light for CS5007 Investigational New Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1163462206","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163462206?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:12","pubTimestamp":1787263936,"startTime":"0","endTime":"0","summary":"CSTONE PHARMA-B (02616) has announced that the Investigational New Drug (IND) application for CS5007, an EGFR/HER3 bispecific antibody-drug conjugate (ADC) and one of the core candidates in the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","IND","NETL","02616","BK4231","ADC","BK1161","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661302932","title":"CStone Gains Rapid China IND Approval for EGFR/HER3 ADC CS5007","url":"https://stock-news.laohu8.com/highlight/detail?id=2661302932","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661302932?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:07","pubTimestamp":1787263635,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals ( ($HK:2616) ) just unveiled an announcement. CStone Pharmaceuticals has secured rapid investigational new drug approval in ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cstone-gains-rapid-china-ind-approval-for-egfr-her3-adc-cs5007?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cstone-gains-rapid-china-ind-approval-for-egfr-her3-adc-cs5007?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4231","PSIL","BK4080","TBXU","IND","ADC","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660404110","title":"Kronox Promoters Agree to Sell Majority Stake to Indo Borax","url":"https://stock-news.laohu8.com/highlight/detail?id=2660404110","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660404110?lang=en_us&edition=fundamental","pubTime":"2026-08-20 15:54","pubTimestamp":1787212446,"startTime":"0","endTime":"0","summary":"Kronox Lab Sciences Limited ( ($IN:KRONOX) ) just unveiled an update. Promoters of Kronox Lab Sciences Limited have signed a share purchase agreeme...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kronox-promoters-agree-to-sell-majority-stake-to-indo-borax?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kronox-promoters-agree-to-sell-majority-stake-to-indo-borax?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","BK4231","BK4080","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491584","title":"Lepu Biopharma Delivers Revenue Growth as ADC Pipeline Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491584","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660491584?lang=en_us&edition=fundamental","pubTime":"2026-08-19 17:19","pubTimestamp":1787131167,"startTime":"0","endTime":"0","summary":"Lepu Biopharma Co. Ltd. Class H ( ($HK:2157) ) has provided an announcement. Lepu Biopharma reported interim revenue of about RMB522.4 million for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lepu-biopharma-delivers-revenue-growth-as-adc-pipeline-advances?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lepu-biopharma-delivers-revenue-growth-as-adc-pipeline-advances?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660493398","title":"Agree Realty Declares Monthly Distribution of R$ 0.12 Per Unit, Payable Aug. 20","url":"https://stock-news.laohu8.com/highlight/detail?id=2660493398","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660493398?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:24","pubTimestamp":1787063059,"startTime":"0","endTime":"0","summary":"Agree Realty declares monthly distribution of R$ 0.12 per unit, payable Aug. 20Agree Realty set a monthly distribution for fiscal 2026 at R$ 0.12 per unit.Shares trade with entitlement through July 29","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL5g6wgw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4231","BK4080","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660232436","title":"Akari Therapeutics Reaffirmed Buy as Analyst Keeps $27 Price Target on Advancing Trop2 ADC and Strengthened PH1 Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2660232436","media":"TIPRANKS","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660232436?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:35","pubTimestamp":1786980940,"startTime":"0","endTime":"0","summary":"Sean Lee CFA, an analyst from H.C. Wainwright, reiterated the Buy rating on Akari Therapeutics. The associated price target remains the same with $...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/akari-therapeutics-reaffirmed-buy-as-analyst-keeps-27-price-target-on-advancing-trop2-adc-and-strengthened-ph1-platform-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/akari-therapeutics-reaffirmed-buy-as-analyst-keeps-27-price-target-on-advancing-trop2-adc-and-strengthened-ph1-platform-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132478153","title":"Breakthrough: AstraZeneca and Daiichi Sankyo's ADC Shows Strong Efficacy in First-Line Lung Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1132478153","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132478153?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:48","pubTimestamp":1786970902,"startTime":"0","endTime":"0","summary":"On August 17, AstraZeneca PLC and Daiichi Sankyo jointly announced that the Phase III DESTINY-Lung04 trial evaluating Enhertu (trastuzumab deruxtecan) as a monotherapy in the first-line treatment of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930573.SGD","LU2089984988.USD","LU2237443895.HKD","BK4080","BK4568","LU0289739699.SGD","ADC","BK4588","LU2468319806.SGD","LU0889565916.HKD","NETL","LU2462157665.USD","BK4007","LU0432979614.USD","LU2237443978.SGD","LU2237443622.USD","BK4231","LU0128525929.USD","LU2417539215.USD","LU2456880835.USD","LU0109394709.USD","IE00B3T34201.USD","LU0029864427.USD","LU2237443465.HKD","LU0708994859.HKD","LU0058720904.USD","LU0320765992.SGD","LU0310800379.SGD","III","BK4585","LU2237443382.USD","AZN","LU1829250122.USD","BK4134","LU2236285917.USD","LU2237443549.SGD","AZNH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660484709","title":"ADC Therapeutics price target lowered to $5 from $10 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2660484709","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660484709?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:13","pubTimestamp":1786965220,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Michael Schmidt lowered the firm’s price target on ADC Therapeutics (ADCT) to $5 from $10 and keeps a Buy rating on the shares. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adc-therapeutics-price-target-lowered-to-5-from-10-at-guggenheim-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adc-therapeutics-price-target-lowered-to-5-from-10-at-guggenheim-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660488402","title":"ADC Therapeutics reports Q2 adjusted EPS (11c) vs. (25c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2660488402","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660488402?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:04","pubTimestamp":1786953842,"startTime":"0","endTime":"0","summary":"Reports Q2 revenue $18.6M, consensus $18.9M. “We are pleased by our Q2 performance, which reflects continued commercial momentum and strong operati...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adc-therapeutics-reports-q2-adjusted-eps-11c-vs-25c-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adc-therapeutics-reports-q2-adjusted-eps-11c-vs-25c-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659763122","title":"Agree Realty (ADC) Earnings Call Highlights Growth, Discipline","url":"https://stock-news.laohu8.com/highlight/detail?id=2659763122","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659763122?lang=en_us&edition=fundamental","pubTime":"2026-08-15 08:17","pubTimestamp":1786753033,"startTime":"0","endTime":"0","summary":"Agree Realty Corporation (($ADC)) has held its Q2 earnings call. Read on for the main highlights of the call. Agree Realty Corporation’s latest ear...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/agree-realty-adc-earnings-call-highlights-growth-discipline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/agree-realty-adc-earnings-call-highlights-growth-discipline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659914054","title":"ADC Therapeutics Balances LOTIS-5 Regulatory Risk With LOTIS-7 Opportunity, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2659914054","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659914054?lang=en_us&edition=fundamental","pubTime":"2026-08-14 22:46","pubTimestamp":1786718801,"startTime":"0","endTime":"0","summary":"ADC Therapeutics (ADCT) faces a tougher regulatory path for LOTIS-5, but strong LOTIS-7 data could create meaningful upside, RBC Capital Markets said in a note emailed Friday.The analysts said they se","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4231","BK4080","BK4539","BK4505","NETL","ADCT","BK4139","BK4007","LENZ","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659514036","title":"Boan Biotechnology Advances First-in-Class CD228 ADC With Positive Early Trial Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2659514036","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659514036?lang=en_us&edition=fundamental","pubTime":"2026-08-14 22:38","pubTimestamp":1786718334,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotechnology Company., Limited. Class H ( ($HK:6955) ) has provided an announcement. Shandong Boan Biotechnology has reported comple...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/boan-biotechnology-advances-first-in-class-cd228-adc-with-positive-early-trial-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/boan-biotechnology-advances-first-in-class-cd228-adc-with-positive-early-trial-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","NETL","BK4231","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196352387","title":"Bioan Biotech's BA1302 (CD228 ADC) Completes China Phase Ia Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1196352387","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196352387?lang=en_us&edition=fundamental","pubTime":"2026-08-14 22:26","pubTimestamp":1786717576,"startTime":"0","endTime":"0","summary":"BOAN BIOTECH (06955) has announced that its independently developed innovative antibody-drug conjugate (ADC) targeting CD228, BA1302, has completed the monotherapy dose-escalation phase (Phase Ia) of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06955","BK4231","NETL","BK4080","ADC","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.agreerealty.com","stockEarnings":[{"period":"1week","weight":0.0015},{"period":"1month","weight":-0.0783},{"period":"3month","weight":-0.0079},{"period":"6month","weight":-0.0684},{"period":"1year","weight":0.0252},{"period":"ytd","weight":0.0318}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0365},{"period":"3month","weight":0.0206},{"period":"6month","weight":0.1111},{"period":"1year","weight":0.1921},{"period":"ytd","weight":0.1232}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Agree Realty Corporation (the Company), a Maryland corporation, is a fully integrated real estate investment trust (REIT) primarily focused on the ownership, acquisition, development and management of retail properties net leased to industry leading tenants. The Company was founded in 1971 by its current Executive Chairman, Richard Agree, and its common stock was listed on the New York Stock Exchange in 1994. As of March 31, 2024, the Company owned 2,161 properties, with a total gross leasable area (GLA) of approximately 44.9 million square feet.","yearOnYearQuotes":[{"month":1,"riseRate":0.59375,"avgChangeRate":-0.003579},{"month":2,"riseRate":0.46875,"avgChangeRate":0.002186},{"month":3,"riseRate":0.5625,"avgChangeRate":0.012831},{"month":4,"riseRate":0.59375,"avgChangeRate":0.003425},{"month":5,"riseRate":0.484848,"avgChangeRate":0.013996},{"month":6,"riseRate":0.666667,"avgChangeRate":0.010466},{"month":7,"riseRate":0.666667,"avgChangeRate":0.022977},{"month":8,"riseRate":0.454545,"avgChangeRate":0.000779},{"month":9,"riseRate":0.46875,"avgChangeRate":-0.006321},{"month":10,"riseRate":0.5625,"avgChangeRate":-0.000339},{"month":11,"riseRate":0.65625,"avgChangeRate":0.003584},{"month":12,"riseRate":0.46875,"avgChangeRate":0.00994}],"exchange":"NYSE","name":"Agree","nameEN":"Agree"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Agree(ADC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Agree,ADC,Agree股票,Agree股票老虎,Agree股票老虎国际,Agree行情,Agree股票行情,Agree股价,Agree股市,Agree股票价格,Agree股票交易,Agree股票购买,Agree股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Agree(ADC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}